Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China
· Delayed Price · Currency is CNY 22.41
-0.03 (-0.13%)
Apr 29, 2026, 3:04 PM CST
SHE:002262 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 22,764 | 24,511 | 24,744 | 27,326 | 24,736 | 15,769 | Upgrade
|
| Market Cap Growth | 0.36% | -0.94% | -9.45% | 10.47% | 56.87% | -2.01% | Upgrade
|
| Enterprise Value | 18,699 | 20,563 | 20,984 | 23,972 | 21,956 | 13,322 | Upgrade
|
| Last Close Price | 22.41 | 24.13 | 23.96 | 26.33 | 23.67 | 14.85 | Upgrade
|
| PE Ratio | 21.12 | 23.18 | 21.64 | 26.35 | 27.46 | 19.77 | Upgrade
|
| Forward PE | 17.65 | 19.46 | 18.59 | 22.41 | 24.31 | 17.58 | Upgrade
|
| PS Ratio | 3.79 | 4.15 | 4.34 | 5.42 | 5.76 | 4.01 | Upgrade
|
| PB Ratio | 2.73 | 3.05 | 3.40 | 4.26 | 4.43 | 3.22 | Upgrade
|
| P/TBV Ratio | 2.81 | 3.14 | 3.50 | 4.38 | 4.49 | 3.27 | Upgrade
|
| P/FCF Ratio | 48.20 | 38.24 | 53.09 | 43.08 | 46.39 | 31.86 | Upgrade
|
| P/OCF Ratio | 24.83 | 22.73 | 27.01 | 27.10 | 28.73 | 22.49 | Upgrade
|
| PEG Ratio | 1.36 | 1.50 | 1.09 | 1.02 | 1.35 | 1.66 | Upgrade
|
| EV/Sales Ratio | 3.11 | 3.48 | 3.68 | 4.76 | 5.11 | 3.39 | Upgrade
|
| EV/EBITDA Ratio | 14.17 | 16.26 | 15.38 | 19.90 | 21.43 | 13.88 | Upgrade
|
| EV/EBIT Ratio | 16.72 | 18.77 | 17.30 | 22.41 | 24.35 | 15.72 | Upgrade
|
| EV/FCF Ratio | 39.59 | 32.08 | 45.02 | 37.79 | 41.17 | 26.91 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.05 | 0.05 | 0.09 | 0.09 | 0.11 | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.11 | 0.15 | 0.18 | 0.17 | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.48 | -0.49 | -0.51 | -0.53 | -0.52 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.12 | -3.12 | -2.73 | -2.81 | -2.82 | -2.66 | Upgrade
|
| Net Debt / FCF Ratio | -8.54 | -6.16 | -7.98 | -5.33 | -5.42 | -5.16 | Upgrade
|
| Asset Turnover | 0.65 | 0.67 | 0.72 | 0.73 | 0.71 | 0.75 | Upgrade
|
| Inventory Turnover | 2.59 | 2.37 | 2.40 | 2.09 | 1.57 | 1.80 | Upgrade
|
| Quick Ratio | 5.00 | 5.18 | 5.00 | 5.64 | 4.88 | 5.01 | Upgrade
|
| Current Ratio | 5.69 | 5.92 | 5.68 | 6.46 | 5.86 | 5.93 | Upgrade
|
| Return on Equity (ROE) | 13.45% | 13.79% | 16.67% | 17.25% | 16.78% | 17.72% | Upgrade
|
| Return on Assets (ROA) | 7.55% | 7.75% | 9.62% | 9.68% | 9.25% | 10.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 23.97% | 25.82% | 32.43% | 33.10% | 31.80% | 34.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.30% | 13.50% | 16.50% | 16.40% | 15.90% | 16.90% | Upgrade
|
| Earnings Yield | 4.72% | 4.31% | 4.62% | 3.79% | 3.64% | 5.06% | Upgrade
|
| FCF Yield | 2.07% | 2.61% | 1.88% | 2.32% | 2.16% | 3.14% | Upgrade
|
| Dividend Yield | 1.78% | 1.66% | 1.50% | 1.21% | 0.84% | 1.35% | Upgrade
|
| Payout Ratio | 34.05% | 34.63% | 28.31% | 19.54% | 22.51% | 12.63% | Upgrade
|
| Buyback Yield / Dilution | -0.48% | 0.50% | -0.53% | 0.53% | -0.22% | 0.24% | Upgrade
|
| Total Shareholder Return | 1.32% | 2.15% | 0.98% | 1.74% | 0.63% | 1.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.